Personal Finance. Money. Investing.

Phoenix Pharma's Acquisition of OCP Répartition

On September 30th, 2022, the French Competition Authority (ADLC) cleared the acquisition of OCP Repartition, subsidiary of McKesson Europe, by Phoenix Group with minor behavioural remedies following Phase I review.

Posted: 19th December 2022 by Katina Hristova
Share this article

This decision follows the unconditional clearance by the European Commission of all other EEA countries and referral back to the ADLC for France.

The deal involved overlaps in the wholesale and retail distribution of pharmaceutical goods in several European countries. The ADLC considered both local markets and a national market taking into account the buyer power of the Pharmaceutical Purchasing Groups which mainly operate at national level. CRA played a pivotal role in showing the role of PPGs and the increasing competitive constraints from players evolving outside the defined market, convincing the ADLC to accept the proposed behavioural remedies.

A CRA team including Laurent Flochel, Romain Bizet, and Sylvestre Boittin Duchesne advised both Parties for the European Commission and the ADLC proceedings.

Q&A with Laurent Flochel

Vice President at Charles River Associates

Tell us more about your involvement in the acquisition.

We have assisted both Parties since the beginning of the project. We have worked extensively to gather the relevant data for each Party and carried out all competitive analysis in the prenotification and then during the notification phase. We have also helped the legal teams with the design of potential remedies.

During the prenotification phase, we assisted the Parties to answer to the numerous questionnaires issued by the European Commission, which has been a very heavy task. The Commission cleared the case in Italy and referred back to the French Competition Authority (ADLC) for the analysis of the French market. We then assisted the Parties in this new phase.

What were some of the challenges you were faced with?

In this market, the competitive interactions between the wholesalers and their clients take place at two levels: at a national or multiregional level with the pharma purchasing groups and at a local level with the pharmacies. The Commission and the ADLC carried out their competitive analysis both at the level of the catchment area of each depot and at the multiregional or national level.

How did you resolve them?

We managed to convince the ADLC that the competitive pressure exerted by the purchasing groups is very important and that the competitive analysis should not be limited to the local level (i.e. at the level of the catchment areas). In this market very precise and granular data are available. It allowed us to calculate very accurate market shares in value at different levels.

What have been some of the key trends you’ve seen in the M&A space this year?

The last two years have been very intense in the M&A activity and there is a clear trend for the various competition authorities to a stricter merger control on both sides of the Atlantic. The CMA in the UK is today probably the toughest agency.

About Finance Monthly

Universal Media logo
Finance Monthly is a comprehensive website tailored for individuals seeking insights into the world of consumer finance and money management. It offers news, commentary, and in-depth analysis on topics crucial to personal financial management and decision-making. Whether you're interested in budgeting, investing, or understanding market trends, Finance Monthly provides valuable information to help you navigate the financial aspects of everyday life.
© 2024 Finance Monthly - All Rights Reserved.
News Illustration

Get our free monthly FM email

Subscribe to Finance Monthly and Get the Latest Finance News, Opinion and Insight Direct to you every month.
chevron-right-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram